Jointown Pharmaceutical Group Co., Ltd (600998.SS)
CNY 4.77
(-0.83%)
CNY 4.77
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.78 Billion | 3.98 Billion | 3.45 Billion | 3.44 Billion | 2.76 Billion | 1.22 Billion |
| Net Income | 2.17 Billion | 2.28 Billion | 2.6 Billion | 3.38 Billion | 1.78 Billion | 1.38 Billion |
| Depreciation & Amortization | 816.45 Million | 736.28 Million | 656.8 Million | 514.33 Million | 497.05 Million | 403.13 Million |
| Deferred income taxes | -138.18 Million | -278.05 Million | 165.01 Million | 227.09 Million | -23.04 Million | -8.09 Million |
| Stock-based compensation | 104.4 Million | 94.35 Million | 80.04 Million | 51.84 Million | 46.7 Million | 108.02 Million |
| Change in working capital | 383.47 Million | -423.92 Million | 197.66 Million | -365 Million | -774.12 Million | -1.56 Billion |
| Other non-cash items | 2.79 Billion | 1.57 Billion | -248.87 Million | -369.47 Million | 1.23 Billion | 1 Billion |
| Investing Cash Flow | 721.98 Million | 1.48 Billion | -2.54 Billion | -1.27 Billion | -1.24 Billion | -1.51 Billion |
| Investments in PPE | -1.04 Billion | -1.24 Billion | -1.38 Billion | -1.45 Billion | -1.19 Billion | -1.81 Billion |
| Acquisitions | 2.25 Billion | -125.86 Million | 8.8 Million | -21.46 Million | 38.06 Million | -9.38 Million |
| Investment purchases | -1.31 Billion | -540.84 Million | -889.84 Million | -572.52 Million | -731.32 Million | -874.56 Million |
| Sales/Maturities of investments | 832.88 Million | 1.39 Billion | 1.57 Billion | 430.29 Million | 560.53 Million | 98.82 Million |
| Other Investing Activities | 1.02 Million | 2 Billion | -1.85 Billion | 345.89 Million | 84.56 Million | 1.08 Billion |
| Financing Cash Flow | -4.35 Billion | -4.9 Billion | -2.01 Billion | -183.53 Million | -2.84 Billion | 2.25 Billion |
| Debt repayment | -814.17 Million | -23.18 Billion | -20.15 Billion | -22.9 Billion | -26.52 Billion | -23.61 Billion |
| Dividends payments | -936.93 Million | -548.62 Million | -914.36 Million | -737.68 Million | -187.37 Million | -967.1 Million |
| Common Stock Repurchased | -2 Billion | -425.75 Million | -113.79 Thousand | -300.01 Million | -600 Million | - |
| Common Stock Issuance | - | 425.75 Million | 113.79 Thousand | 300.01 Million | 600 Million | -31.52 Million |
| Other Financing Activities | -504.6 Million | 19.67 Billion | 19.81 Billion | 23.45 Billion | 24.82 Billion | 26.82 Billion |
| Accounts receivables | 1.33 Billion | -4.44 Billion | -2.97 Billion | -4.15 Billion | -2.42 Billion | -6.83 Billion |
| Accounts payables | 1.87 Billion | 5.93 Billion | 3.72 Billion | 4.3 Billion | 2.73 Billion | 7.59 Billion |
| Inventory | -2.82 Billion | -1.63 Billion | -720.4 Million | -737.5 Million | -1.05 Billion | -2.31 Billion |
| Other working capital | 104.4 Million | -278.05 Million | 165.01 Million | 227.09 Million | -23.04 Million | 750.71 Million |
| Cash at beginning of period | 17.17 Billion | 7.07 Billion | 8.18 Billion | 6.2 Billion | 7.51 Billion | 5.55 Billion |
| Cash at end of period | 16.94 Billion | 7.66 Billion | 7.07 Billion | 8.18 Billion | 6.2 Billion | 7.51 Billion |
| Capital Expenditure | -1.04 Billion | -1.24 Billion | -1.38 Billion | -1.45 Billion | -1.19 Billion | -1.81 Billion |
| Effect of forex changes on cash | -1 Million | 9.6 Million | -3.49 Million | -3.47 Million | 711.88 Thousand | -367.74 Thousand |
| Net cash flow / Change in cash | -226.78 Million | 582.98 Million | -1.1 Billion | 1.98 Billion | -1.31 Billion | 1.95 Billion |
| Free Cash Flow | 3.73 Billion | 2.74 Billion | 2.07 Billion | 1.98 Billion | 1.57 Billion | -592.8 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 488.54 Million | 669.96 Million | 537.67 Million | 2.17 Billion | 350.36 Million | 480.68 Million |
| Depreciation & Amortization | - | 218.73 Million | 218.73 Million | 816.45 Million | 203.67 Million | -365.48 Million |
| Deferred income taxes | - | - | - | -138.18 Million | - | -3.66 Billion |
| Stock-based compensation | - | 50.56 Million | - | 104.4 Million | 104.4 Million | -47.8 Million |
| Change in working capital | - | -6.31 Billion | - | 383.47 Million | -1.39 Billion | 4.07 Billion |
| Other non-cash items | 59.08 Million | 3.04 Million | -4.18 Billion | 2.79 Billion | 3.82 Billion | -196.94 Million |
| Investing Cash Flow | -928.1 Million | 5.75 Million | 497.69 Million | 721.98 Million | 793.55 Million | -189.09 Million |
| Investments in PPE | -238.9 Million | -215.61 Million | -216.71 Million | -1.04 Billion | -303.04 Million | -211.06 Million |
| Acquisitions | -384.91 Thousand | 263.77 Million | 832.51 Million | 2.25 Billion | 1.51 Billion | 29.3 Million |
| Investment purchases | -801.58 Million | -2.03 Billion | -145.63 Million | -1.31 Billion | -906.75 Million | -61.66 Million |
| Sales/Maturities of investments | 296.01 Million | 2.01 Billion | 31.34 Million | 832.88 Million | 472.16 Million | 48.48 Million |
| Other Investing Activities | -183.24 Million | 1.72 Million | -3.81 Million | 1.02 Million | 13.28 Million | 5.83 Million |
| Financing Cash Flow | -473.16 Million | 1.13 Billion | 672.69 Million | -4.35 Billion | -2.21 Billion | -607.82 Million |
| Debt repayment | -2.27 Billion | -1.85 Billion | -1.75 Billion | -814.17 Million | -1.81 Billion | -3.45 Billion |
| Dividends payments | -125.89 Million | -977.22 Million | -246.7 Million | -936.93 Million | -936.93 Million | -936.93 Million |
| Common Stock Repurchased | 93.06 Million | -93.06 Million | - | -2 Billion | -2 Billion | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.93 Billion | 406.38 Million | -1.08 Billion | -504.6 Million | 3.39 Billion | 3.11 Billion |
| Accounts receivables | - | -8.29 Billion | - | 1.33 Billion | 1.33 Billion | 4.5 Billion |
| Accounts payables | - | - | - | 1.87 Billion | - | - |
| Inventory | - | 1.92 Billion | - | -2.82 Billion | -2.82 Billion | -434.96 Million |
| Other working capital | - | 50.56 Million | - | 104.4 Million | 104.4 Million | -47.8 Million |
| Cash at beginning of period | 7.92 Billion | 14.39 Billion | 16.94 Billion | 17.17 Billion | 14.32 Billion | 6.77 Billion |
| Cash at end of period | 7.06 Billion | 16.24 Billion | 14.39 Billion | 16.94 Billion | 16.94 Billion | 6.25 Billion |
| Capital Expenditure | -238.9 Million | -215.61 Million | -216.71 Million | -1.04 Billion | -303.04 Million | -211.06 Million |
| Effect of forex changes on cash | 162.98 Thousand | -1.21 Million | -140.49 Thousand | -1 Million | -1.3 Million | -408.67 Thousand |
| Net cash flow / Change in cash | -858.1 Million | 1.85 Billion | -2.55 Billion | -226.78 Million | 2.62 Billion | -516.5 Million |
| Free Cash Flow | 308.72 Million | 238.65 Million | -3.86 Billion | 3.73 Billion | 3.67 Billion | 69.76 Million |
LUCK
AMOSF
MMLP
CPPKF
IBWC
ISHANCH